Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Transplantation Proceedings|December 20, 2007
Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantationL Annemans, H Lemkuhl, G Tenderich, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 20, 2010
Deriving reference values and utilities for the QoL-AGHDA in adult GHDJ J V Busschbach, B H R Wolffenbuttel, L Annemans, et al.Arthritis and Rheumatism|March 4, 2008
Health economic consequences related to the diagnosis of fibromyalgia syndromeL Annemans, S Wessely, E Spaepen, et al.BMC Geriatrics|January 18, 2020
Factors associated with costs of care in community-dwelling persons with dementia from a third party payer and societal perspective: a cross-sectional studyS Vandepitte, L Van Wilder, K Putman, et al.Acta Clinica Belgica|April 12, 2005
Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in BelgiumL Annemans, M C Minjoulat-Rey, M De Knock, et al.Current Medical Research and Opinion|February 6, 2009
Fentanyl HCl iontophoretic transdermal system versus morphine IV-PCA for postoperative pain management: survey of healthcare provider opinionF Bonnet, L Eberhart, E Wennberg, et al.Journal of Clinical Pharmacy and Therapeutics|December 15, 2010
Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trialE Mehuys, L Van Bortel, L De Bolle, et al.The European Respiratory Journal|December 21, 2007
Effectiveness of pharmacist intervention for asthma control improvementE Mehuys, L Van Bortel, L De Bolle, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 4, 2003
Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patientsL Annemans, K Moeremans, M Lamotte, et al.Pharmacoeconomics|February 6, 1997
Pricing and reimbursement of pharmaceuticals in BelgiumL Annemans, R Crott, H De Clercq, et al.Pageof 8